Fierce Healthcare October 18, 2023
Changes to the Medicare Part D program—including capping insulin copays and out-of-pocket spending and eliminating the 5% coinsurance requirement for the catastrophic phase—from the Inflation Reduction Act (IRA) could negatively impact payers, according to a survey of health plans.
The survey, conducted by Cencora’s Managed Care Network and presented at AMCP Nexus yesterday, asked 50 health payers in March for their initial reaction to changes to Medicare Part D. While payers disagreed about some of its impact, or were not certain of its potential effects, many payers agreed the changes would be negative to their interests.
Of the respondents, 44% of payers think the changes will have an adverse impact on their portfolio of Part D plans and 34% think...
Today's Sponsors
Today's Sponsor